Epitranscriptomic Dynamics in Brain Development and Disease
Overview
Authors
Affiliations
Distinct cell types are generated at specific times during brain development and are regulated by epigenetic, transcriptional, and newly emerging epitranscriptomic mechanisms. RNA modifications are known to affect many aspects of RNA metabolism and have been implicated in the regulation of various biological processes and in disease. Recent studies imply that dysregulation of the epitranscriptome may be significantly associated with neuropsychiatric, neurodevelopmental, and neurodegenerative disorders. Here we review the current knowledge surrounding the role of the RNA modifications N6-methyladenosine, 5-methylcytidine, pseudouridine, A-to-I RNA editing, 2'O-methylation, and their associated machinery, in brain development and human diseases. We also highlight the need for the development of new technologies in the pursuit of directly mapping RNA modifications in both genome- and single-molecule-level approach.
Hashmi M, Fatima H, Ahmad S, Rehman A, Safdar F Ibrain. 2024; 10(4):395-426.
PMID: 39691424 PMC: 11649393. DOI: 10.1002/ibra.12183.
RNA methylation in neurodevelopment and related diseases.
Xia W, Liu Y, Lu J, Cheung H, Meng Q, Huang B Acta Biochim Biophys Sin (Shanghai). 2024; 56(12):1723-1732.
PMID: 39344412 PMC: 11693867. DOI: 10.3724/abbs.2024159.
He D, He X, Shen D, Liu L, Yang X, Hao M MedComm (2020). 2024; 5(9):e712.
PMID: 39263607 PMC: 11387721. DOI: 10.1002/mco2.712.
Emerging Role of Environmental Epitranscriptomics and RNA Modifications in Parkinson's Disease.
Gionco J, Bernstein A J Parkinsons Dis. 2024; 14(4):643-656.
PMID: 38578904 PMC: 11191529. DOI: 10.3233/JPD-230457.
N-methylation in the development, diagnosis, and treatment of gastric cancer.
Wang J, Zhao G, Zhao Y, Zhao Z, Yang S, Zhou A J Transl Int Med. 2024; 12(1):5-21.
PMID: 38525439 PMC: 10956730. DOI: 10.2478/jtim-2023-0103.